DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer

Oncogene

Volumn 34, Issue 20, 2015, Pages 2575-2585

  Wang, S ^a,b   Dong, Y ^b   Zhang, Y ^c   Wang, X ^b   Xu, L ^a,b   Yang, S ^c   Li, X ^b   Dong, H ^a   Su, L ^a   Ng, S S M ^b   Chang, Z ^c   Sung, J J ^b   Zhang, X ^a   Yu, J ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CARRIER PROTEIN; DACT2 PROTEIN, HUMAN; LEF1 PROTEIN, HUMAN; LYMPHOID ENHANCER FACTOR 1; NUCLEAR LOCALIZATION SIGNAL; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACTIVE TRANSPORT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL; BAGG ALBINO MOUSE; CACO 2 CELL LINE; CELL NUCLEUS; COLON TUMOR; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; MORTALITY; MOUSE; NUCLEAR LOCALIZATION SIGNAL; NUDE MOUSE; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY; WNT SIGNALING PATHWAY;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ANIMALS; BETA CATENIN; CACO-2 CELLS; CADHERINS; CARRIER PROTEINS; CELL NUCLEUS; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; NUCLEAR LOCALIZATION SIGNALS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS; WNT SIGNALING PATHWAY;

EID: 84938068432     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.201     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011; 8: 686-700.
3. Brott BK, Sokol SY. Frodo proteins: Modulators of Wnt signaling in vertebrate development. Differentiation 2005; 73: 323-329.
4. Waxman JS, Hocking AM, Stoick CL, Moon RT. Zebrafish Dapper1 and Dapper2 play distinct roles in Wnt-mediated developmental processes. Development 2004; 131: 5909-5921.
5. Yuan G, Wang C, Ma C, Chen N, Tian Q, Zhang T et al. Oncogenic function of DACT1 in colon cancer through the regulation of ?-catenin. PLoS ONE 2012; 7: E34004.
6. Suriben R, Kivimäe S, Fisher DA, Moon RT, Cheyette BN. Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak. Nat Genet 2009; 41: 977-985.
7. Wang S, Kang W, Go MY, Tong JH, Li L, Zhang N et al. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-?B signaling pathway. Mol Med 2012; 18: 1402-1411.
8. Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer. J Pathol 2013; 230: 194-204.
9. Cheyette BN, Waxman JS, Miller JR, Takemaru K, Sheldahl LC, Khlebtsova N et al. Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell 2002; 2: 449-461.
10. Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem 2006; 281: 17751-17757.
11. Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010; 2: A002915.
12. Valenta T, Hausmann G, Basler K. The many faces and functions of ?-catenin. EMBO J 2012; 31: 2714-2736.
13. Neufeld KL, Nix DA, Bogerd H, Kang Y, Beckerle MC, Cullen BR et al. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci USA 2000; 97: 12085-12090.
14. Neufeld KL. Nuclear APC. Adv Exp Med Biol 2009; 656: 13-29.
15. Zhang L, Gao X, Wen J, Ning Y, Chen YG. Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J Biol Chem 2006; 281: 8607-8612.
16. Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 2008; 13: 529-541.
17. Gao C, Chen YG. Dishevelled: The hub of Wnt signaling. Cell Signal 2010; 22: 717-727.
18. Cadigan KM, Waterman ML. TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol 2012; 4: Pii a007906.
19. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25: 7531-7537.
20. Metcalfe C, Bienz M. Inhibition of GSK3 by Wnt signalling-two contrasting models. J Cell Sci 2011; 124: 3537-3544.
21. Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, MacCoss MJ et al. The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat Cell Biol 2006; 8: 348-357.
22. Wei W, Li M, Wang J, Nie F, Li L. The E3 ubiquitin ligase ITCH negatively regulates canonical Wnt signaling by targeting dishevelled protein. Mol Cell Biol 2012; 32: 3903-3912.
23. Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W et al. Analysis of the betacatenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res 2002; 93: 1213-1220.
24. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.
25. Kivimäe S, Yang XY, Cheyette BN. All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases. BMC Biochem 2011; 12: 33.
26. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
27. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
28. Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA 2011; 108: 11930-11935.
29. Perrais M, Chen X, Perez-Moreno M, Gumbiner BM. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 2007; 18: 2013-2025.
30. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
31. Brenner C, Deplus R, Didelot C, Loriot A, Viré E, De Smet C et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J 2005; 24: 336-346.
32. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: Mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143: 550-563.
33. Choi SW, Friso S. Epigenetics: A new bridge between nutrition and health. Adv Nutr 2010; 1: 8-16.
34. Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H et al. Earlystage formation of an epigenetic field defect in a mouse colitis model, and nonessential roles of T-and B-cells in DNA methylation induction. Oncogene 2012; 31: 342-351.
35. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998; 58: 3942-3945.
36. Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S et al. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene 2010; 29: 6464-6474.
37. Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang H et al. Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut 2013; 62: 833-841.
38. Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006; 25: 1070-1080.
39. Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N et al. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology 2006; 43: 826-836.